Adaptive Approach to Naltrexone Treatment for Alcoholism

Naltrexone (NTX) is an opioid receptor antagonist used to prevent alcoholism relapse. This trial examines how to define “non-response” to treatment with NTX and what treatments are most effective for those who do or do not respond to the initial treatment. More details about this study can be found on the SMART Example page.

  • PI: David Oslin
  • Location: University of Pennsylvania
  • Funding: NIAAA Project R01AA017164